Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

A new system was created to classify skin changes in cancer patients based on their treatment.

Most types of hair loss can regrow naturally, but there are no effective cures for male pattern or age-related hair loss, and only limited options for females.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Galla chinensis solution effectively treats fungal skin infections in dogs.

New treatments for hair loss are being developed using molecular biology.

Curcumin nanocrystal gel improves skin absorption and is safe and effective for topical use.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Breast cancer patients often worry, lose weight, and cope by praying, meditating, or seeking support.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.